Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||
net income | 5,205,000 | -5,487,000 | -464,000 | -8,452,000 | 17,048,000 | -712,000 | 1,850,000 | 4,799,000 | 12,934,000 | 1,003,000 | -3,788,000 | 5,970,000 | 11,187,000 | 19,152,000 | -1,115,000 | 5,493,000 | 8,896,000 | -4,652,000 | -14,265,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||
depreciation, depletion and amortization | 8,341,000 | 7,029,000 | 6,264,000 | 6,210,000 | 6,048,000 | 5,823,000 | 5,434,000 | 5,366,000 | 5,345,000 | 5,251,000 | 5,196,000 | 5,167,000 | 5,133,000 | 5,153,000 | 5,807,000 | 5,666,000 | 5,659,000 | 5,737,000 | |
benefit for deferred income taxes | -333,000 | -81,000 | 249,000 | -13,033,000 | -236,000 | 3,128,000 | -3,138,000 | 3,196,000 | 1,066,000 | ||||||||||
stock-based compensation | 815,000 | 2,365,000 | 1,274,000 | 1,343,000 | 4,277,000 | 2,098,000 | 2,241,000 | 2,323,000 | 2,500,000 | 1,725,000 | 1,770,000 | 2,454,000 | 2,751,000 | 2,297,000 | 2,334,000 | 2,706,000 | 2,574,000 | 2,541,000 | 14,598,000 |
derivative mark-to-market adjustments and settlements | 107,000 | 127,000 | 214,000 | -162,000 | 674,000 | 65,000 | -91,000 | 720,000 | -41,000 | -515,000 | 396,000 | -1,293,000 | -1,515,000 | -287,000 | |||||
net income on sale of assets | 0 | 21,000 | 15,000 | 1,000 | 49,000 | 22,000 | 800,000 | ||||||||||||
increase in earn-out liability | 274,000 | 41,000 | -1,279,000 | 384,000 | -849,000 | 307,000 | 609,000 | 136,000 | 214,000 | ||||||||||
accretion of asset retirement obligations | 123,000 | 121,000 | 118,000 | 112,000 | 113,000 | 112,000 | 108,000 | 103,000 | 102,000 | 102,000 | 100,000 | 122,000 | 47,000 | 29,000 | 98,000 | -464,000 | 89,000 | 77,000 | 138,000 |
liabilities associated with properties sold | 0 | 0 | 0 | -225,000 | |||||||||||||||
amortization of debt issuance costs | 99,000 | 98,000 | 97,000 | 90,000 | 90,000 | 90,000 | 90,000 | 91,000 | 92,000 | 91,000 | 93,000 | 98,000 | 102,000 | 104,000 | 108,000 | 88,000 | 124,000 | 134,000 | 137,000 |
impairment loss | 48,000 | 377,000 | 2,047,000 | 354,000 | 533,000 | 171,000 | 528,000 | 125,000 | 51,000 | 275,000 | 451,000 | 2,459,000 | 2,273,000 | 69,000 | 51,000 | 565,000 | 0 | 0 | 626,000 |
changes in operating assets and liabilities: | |||||||||||||||||||
accounts receivable | 1,525,000 | 948,000 | -319,000 | ||||||||||||||||
royalty offset long term receivable | -1,463,000 | -1,906,000 | -739,000 | ||||||||||||||||
critical spare inventory | -319,000 | -815,000 | -215,000 | ||||||||||||||||
prepaid insurance and expenses | 746,000 | ||||||||||||||||||
income tax receivable | |||||||||||||||||||
accounts payable and accrued liabilities | -881,000 | 5,034,000 | 2,213,000 | ||||||||||||||||
other | -28,000 | -114,000 | -304,000 | ||||||||||||||||
net cash from operating activities | 12,651,000 | 8,206,000 | 9,140,000 | 724,000 | 28,586,000 | 193,000 | 14,292,000 | 21,466,000 | 13,510,000 | 17,915,000 | -11,838,000 | 21,257,000 | 33,037,000 | 17,175,000 | 9,597,000 | 21,581,000 | 10,053,000 | 3,476,000 | 7,769,000 |
cash flows from investing activities: | |||||||||||||||||||
capital expenditures | -29,808,000 | -33,666,000 | -11,632,000 | -8,989,000 | -12,570,000 | -18,778,000 | -21,986,000 | -17,685,000 | -15,818,000 | -16,310,000 | -13,278,000 | -9,527,000 | -7,602,000 | -2,770,000 | -2,378,000 | -2,284,000 | -3,233,000 | -3,134,000 | -1,335,000 |
free cash flows | -17,157,000 | -25,460,000 | -2,492,000 | -8,265,000 | 16,016,000 | -18,585,000 | -7,694,000 | 3,781,000 | -2,308,000 | 1,605,000 | -25,116,000 | 11,730,000 | 25,435,000 | 14,405,000 | 7,219,000 | 19,297,000 | 6,820,000 | 342,000 | 6,434,000 |
asset acquisition | 0 | 0 | 0 | -820,000 | 0 | ||||||||||||||
capital contributions to equity method investments | -2,017,000 | ||||||||||||||||||
cash collateral deposits | 52,000 | -73,000 | -4,000 | 9,000 | 20,000 | 0 | 1,000 | 3,000 | -338,000 | ||||||||||
net cash from investing activities | -31,773,000 | -35,814,000 | -11,632,000 | -8,062,000 | -12,574,000 | -18,769,000 | -22,786,000 | -17,683,000 | -15,817,000 | -16,309,000 | -13,278,000 | -9,524,000 | -7,523,000 | -2,770,000 | -977,000 | -8,060,000 | -2,893,000 | -7,268,000 | -1,253,000 |
cash flows from financing activities: | |||||||||||||||||||
repayments of long term debt | |||||||||||||||||||
borrowings on revolver | |||||||||||||||||||
repayments on revolver | |||||||||||||||||||
contingent consideration payment | |||||||||||||||||||
common stock issuance | 0 | 1,000 | 3,000 | ||||||||||||||||
treasury stock purchase | 0 | -71,000 | -1,312,000 | -147,000 | 0 | 0 | -91,000 | 0 | 0 | 0 | -10,813,000 | ||||||||
finance lease payments | -17,000 | -18,000 | -18,000 | -17,000 | -19,000 | -12,000 | -20,000 | -20,000 | -18,000 | -18,000 | -18,000 | -32,000 | -11,000 | ||||||
net cash provided (used) in financing activities | -3,193,000 | ||||||||||||||||||
net decrease in cash and cash equivalents and restricted cash | -22,315,000 | -10,976,000 | -5,510,000 | -9,425,000 | 12,684,000 | -20,983,000 | -10,514,000 | ||||||||||||
cash and cash equivalents and restricted cash at beginning of period | 0 | 0 | 46,004,000 | 0 | 0 | 0 | 74,242,000 | 0 | 0 | 0 | 105,606,000 | 0 | 0 | 53,612,000 | 0 | 0 | 21,559,000 | ||
cash and cash equivalents and restricted cash at end of period | -22,315,000 | -10,976,000 | 40,494,000 | -9,425,000 | 12,684,000 | -20,983,000 | 63,728,000 | 507,000 | -4,325,000 | -412,000 | 78,472,000 | 23,503,000 | 12,401,000 | 60,141,000 | 4,660,000 | -6,292,000 | 23,215,000 | ||
reconciliation of cash, cash equivalents, and restricted cash at end of period: | |||||||||||||||||||
cash and cash equivalents | -22,367,000 | -10,978,000 | 40,111,000 | -9,352,000 | 12,688,000 | -20,992,000 | 63,277,000 | 507,000 | -4,326,000 | -413,000 | 78,043,000 | 9,558,000 | 23,424,000 | 12,401,000 | 59,794,000 | 32,374,000 | 4,542,000 | -6,293,000 | 22,643,000 |
restricted cash and cash equivalents - current | 0 | 0 | 8,000 | -74,000 | 74,000 | 0 | 8,000 | -14,000 | 0 | 0 | 22,000 | 0 | 0 | 19,000 | |||||
restricted cash and cash equivalents - non-current | 52,000 | 2,000 | 375,000 | 1,000 | -78,000 | 9,000 | 443,000 | 14,000 | 1,000 | 1,000 | 407,000 | 79,000 | 0 | 328,000 | 0 | 1,000 | 572,000 | ||
benefit from deferred income taxes | -1,240,000 | 90,000 | 1,699,000 | 2,211,000 | |||||||||||||||
income tax payables | -303,000 | -303,000 | |||||||||||||||||
borrowings on long term debt | |||||||||||||||||||
repayments of long-term debt | -3,000,000 | -3,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -59,198,000 | -2,500,000 | -2,500,000 | -2,500,000 | |
decrease in earn-out liability | -425,000 | ||||||||||||||||||
net cash from financing activities | -3,018,000 | -2,087,000 | -3,328,000 | -2,407,000 | -2,020,000 | -3,276,000 | -2,018,000 | -2,018,000 | -2,018,000 | -2,173,000 | -2,011,000 | -2,004,000 | -2,091,000 | 18,509,000 | -2,500,000 | -2,500,000 | -4,860,000 | ||
gain on property insurance proceeds | 0 | 0 | 0 | -313,000 | -94,000 | -156,000 | 0 | -82,000 | |||||||||||
cash provided (used) by changes in assets and labilities: | |||||||||||||||||||
proceeds from insurance recovery | 0 | 0 | 0 | 313,000 | 94,000 | 156,000 | 0 | 82,000 | |||||||||||
proceeds from sale of assets | 0 | 0 | 0 | 1,088,000 | -1,000 | 66,000 | |||||||||||||
related party receivable | |||||||||||||||||||
accounts and other receivables and other current assets | 3,937,000 | -15,573,000 | 1,639,000 | 8,303,000 | -4,877,000 | -14,279,000 | 1,033,000 | 2,198,000 | 12,737,000 | -20,938,000 | 2,949,000 | 5,750,000 | -3,719,000 | -6,187,000 | 2,634,000 | ||||
accounts payable and other accrued expenses | -4,732,000 | 7,767,000 | 3,296,000 | -818,000 | -4,904,000 | 11,006,000 | -4,307,000 | 3,369,000 | -1,685,000 | 8,158,000 | -1,554,000 | -2,637,000 | -102,000 | 2,992,000 | -2,402,000 | ||||
supplemental cash flow information: | |||||||||||||||||||
cash paid for interest | 1,529,000 | 1,129,000 | 1,237,000 | 1,290,000 | 1,253,000 | ||||||||||||||
cash paid for income taxes | 0 | 833,000 | 574,000 | 881,000 | 169,000 | ||||||||||||||
accrual for purchase of property, plant and equipment included in accounts payable and accrued liabilities | -769,000 | 205,000 | 7,492,000 | 2,876,000 | -3,970,000 | ||||||||||||||
loss on extinguishment of debt | |||||||||||||||||||
net gain on sale of assets | 57,000 | 0 | 0 | 37,000 | -293,000 | ||||||||||||||
asset acquisitions | |||||||||||||||||||
borrowings of long-term debt | |||||||||||||||||||
debt issuance costs | |||||||||||||||||||
debt extinguishment costs | |||||||||||||||||||
net increase in cash and cash equivalents and restricted cash | 507,000 | -4,325,000 | -412,000 | -27,134,000 | 9,560,000 | 23,503,000 | 12,401,000 | 6,529,000 | 4,660,000 | -6,292,000 | 1,656,000 | ||||||||
depreciation and amortization | |||||||||||||||||||
related party receivables | |||||||||||||||||||
net (gain) loss on sale of assets | 17,000 | 43,000 | |||||||||||||||||
cash flows from investing activities | |||||||||||||||||||
cash and cash equivalents and restricted cash at beginning of year | |||||||||||||||||||
cash and cash equivalents and restricted cash at end of year | |||||||||||||||||||
reconciliation of cash, cash equivalents, and restricted cash at end of year: | |||||||||||||||||||
restricted cash and cash equivalents-current | |||||||||||||||||||
restricted cash and cash equivalents-non-current | |||||||||||||||||||
cash paid (refunded) for income taxes | |||||||||||||||||||
earn out increase | -281,000 | ||||||||||||||||||
proceeds from initial public offering | 0 | 0 | 0 | 15,593,000 | |||||||||||||||
loan to montauk holdings limited | 0 | 0 | -7,140,000 | ||||||||||||||||
derivative mark-to-market and settlements | 2,415,000 | -418,000 | |||||||||||||||||
loss on earn-out liability increase | |||||||||||||||||||
equity (income) of nonconsolidated investments | |||||||||||||||||||
proceeds from sale of equity method investments | |||||||||||||||||||
class b shareholder repurchase | |||||||||||||||||||
net increase or decrease in cash and cash equivalents and restricted cash | |||||||||||||||||||
buildings and improvements | |||||||||||||||||||
machinery and equipment | |||||||||||||||||||
gas mineral rights | |||||||||||||||||||
gain on pico earn-out liability reduction | |||||||||||||||||||
non-cash asset held for sale transfer | |||||||||||||||||||
net (gain)/loss on sale of assets | |||||||||||||||||||
inventory obsolescence | |||||||||||||||||||
equity (income) loss of nonconsolidated investments | |||||||||||||||||||
distributions from equity method investment | |||||||||||||||||||
acquisitions, net of cash received | |||||||||||||||||||
dividends | |||||||||||||||||||
capital expenditures financed by accounts payable | |||||||||||||||||||
change in asset retirement obligation estimate |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
